Effects of statin use on the response duration to androgen deprivation therapy in metastatic prostate cancer.
Jaeyoon JungChunwoo LeeChanwoo LeeTaekmin KwonDalsan YouIn Gab JeongJun Hyuk HongHanjong AhnChoung-Soo Kim
Published in: Korean journal of urology (2015)
Statin use in metastatic prostate cancer patients appears to delay the progression to CRPC. Large-scale, long-term follow-up studies are needed to validate this finding.